Skip to content

Epidemiology and Risk Factors of Uterine Fibroids in China

Epidemiology and Risk Factors of Uterine Fibroids in China

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05840042
Enrollment
20000
Registered
2023-05-03
Start date
2023-06-19
Completion date
2026-12-31
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Fibroid

Brief summary

Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.

Interventions

None listed

Sponsors

Women's Hospital School Of Medicine Zhejiang University
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
The Fourth Hospital of Shijiazhuang
CollaboratorOTHER
Shixuan Wang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Current place of residence≥ 6 months; * No serious mental illness or mental abnormality; * Those who agree to participate in this survey and cooperate in completing the questionnaire.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of uterine fibroids in ChinaBaselinePrevalence of uterine fibroids in China

Secondary

MeasureTime frameDescription
Incidence of uterine fibroids in ChinaTwo follow-ups over a three-year periodIncidence of uterine fibroids in China
Risk factors of development of uterine fibroids in ChinaTwo follow-ups over a three-year periodAssociated risk factors for recurrence, infertility and malignancy of uterine fibroids in China

Contacts

Primary ContactWENWEN WANG, DOCTOR
petrawang@163.com15927167698
Backup ContactMINLI ZHANG, MASTER

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026